Pancreatic Cancer Research

ResearcherMedical University of GrazNo recent work listed

Anna Lena Lembeck

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5076630275. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

  1. Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer. Co-author DOI 10.1515/cclm-2018-0016↗
  2. Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis. Co-author DOI 10.1007/s00508-018-1383-3↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Stotz · 2 shared papers, 2018–2019 · strength 0.16
  2. Joanna Szkandera · 2 shared papers, 2018–2019 · strength 0.16
  3. Armin Gerger · 2 shared papers, 2018–2019 · strength 0.16
  4. Martin Pichler · 2 shared papers, 2018–2019 · strength 0.16
  5. Peter Kornprat · 2 shared papers, 2018–2019 · strength 0.16
  6. Konstantin Schlick · 2 shared papers, 2018–2019 · strength 0.16
  7. Eva Valentina Klocker · 1 shared paper, 2019 · strength 0.09
  8. Eva Asamer · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.